Celestica Inc. CLS
259.94 USD +10.72 (+4.30%)
At closeNov 3, 2026, 7:55 PM EST
258.00 -1.94 -0.75%
After hours · Nov 3, 7:55 PM ET
253.00 Day range 263.23
244.51 52-week range 474.03
- YTD
- -12.07%
- 1 year
- -25.52%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 464.78 +78.8% upside
Now 259.94
- Target (low)
- 385.00
- Target (mean)
- 464.78
- Target (high)
- 535.00
Ratings (0m) 21 21 buy · 0 hold · 0 sell
- Strong buy5
- Buy16
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 22
- 2 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.45 | 3.26 – 3.77 | 2.31 | +49.4% | 6.47B | +77.0% | 6 |
| Next quarter | 3.92 | 3.58 – 4.35 | 2.16 | +81.5% | 7.43B | +83.5% | 14 |
| Current year | 11.56 | 11.43 – 11.69 | 6.05 | +91.0% | 21.04B | +69.8% | 20 |
| Next year | 21.76 | 20.65 – 23.60 | 11.63 | +87.0% | 40.19B | +91.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | UBS | Maintained | Buy | Buy |
| Oct 28, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 28, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 30, 2026 | Bernstein | Initiated | — | Outperform |
| Sep 15, 2026 | FBN Securities | Initiated | — | Outperform |
| Aug 24, 2026 | UBS | Upgrade | Neutral | Buy |
| Aug 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 29, 2026 | Wolfe Research | Maintained | Outperform | Outperform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 1, 2026 | Rothschild & Co | Initiated | — | Buy |
| Apr 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 29, 2026 | TD Cowen | Upgrade | Hold | Buy |
| Apr 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 29, 2026 | Susquehanna | Maintained | Positive | Positive |
| Apr 24, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Apr 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 20, 2026 | TD Cowen | Maintained | Hold | Hold |
| Apr 16, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 11, 2026 | CIBC | Maintained | Outperformer | Outperformer |
| Jan 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Dec 1, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 14, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 10, 2025 | Citigroup | Upgrade | Neutral | Buy |
| Oct 29, 2025 | CIBC | Maintained | Outperformer | Outperformer |
| Oct 29, 2025 | TD Securities | Maintained | Hold | Hold |
